These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20003143)

  • 1. Blood concentrations of midazolam in status epilepticus using an appropriate condition of HPLC.
    Iwasaki T; Nonoda Y; Ishii M; Osawa M
    Pediatr Int; 2010 Aug; 52(4):513-9. PubMed ID: 20003143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of midazolam and its major metabolite 1'-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children.
    Muchohi SN; Ward SA; Preston L; Newton CR; Edwards G; Kokwaro GO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(1):1-7. PubMed ID: 15914101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal midazolam as first-line inhospital treatment for status epilepticus: a pharmaco-EEG cohort study.
    Kay L; Merkel N; von Blomberg A; Willems LM; Bauer S; Reif PS; Schubert-Bast S; Rosenow F; Strzelczyk A
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2413-2425. PubMed ID: 31682078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring.
    von Blomberg A; Kay L; Knake S; Fuest S; Zöllner JP; Reif PS; Herrmann E; Balaban Ü; Schubert-Bast S; Rosenow F; Strzelczyk A
    CNS Drugs; 2020 May; 34(5):545-553. PubMed ID: 32219682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam.
    Bodmer M; Link B; Grignaschi N; Kummer O; Ruegg S; Haschke M; Krähenbühl S
    Ther Drug Monit; 2008 Feb; 30(1):120-4. PubMed ID: 18223475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease.
    Tuey SM; Prebehalla L; Roque AA; Roda G; Chonchol MB; Shah N; Wempe MF; Hu Y; Hogan SL; Nolin TD; Joy MS
    J Clin Pharmacol; 2022 Dec; 62(12):1528-1538. PubMed ID: 35678297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose midazolam infusion for refractory status epilepticus.
    Fernandez A; Lantigua H; Lesch C; Shao B; Foreman B; Schmidt JM; Hirsch LJ; Mayer SA; Claassen J
    Neurology; 2014 Jan; 82(4):359-65. PubMed ID: 24363133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of intravenous midazolam in status epilepticus in children].
    Lemerle J; Daoud P; Moutard ML; Desguerre I; Rodriguez D
    Arch Pediatr; 1995 Sep; 2(9):848-53. PubMed ID: 7581780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study.
    Charalambous M; Volk HA; Tipold A; Erath J; Huenerfauth E; Gallucci A; Gandini G; Hasegawa D; Pancotto T; Rossmeisl JH; Platt S; De Risio L; Coates JR; Musteata M; Tirrito F; Cozzi F; Porcarelli L; Corlazzoli D; Cappello R; Vanhaesebrouck A; Broeckx BJG; Van Ham L; Bhatti SFM
    J Vet Intern Med; 2019 Nov; 33(6):2709-2717. PubMed ID: 31580527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis.
    Johnson TN; Rostami-Hodjegan A; Goddard JM; Tanner MS; Tucker GT
    Br J Anaesth; 2002 Sep; 89(3):428-37. PubMed ID: 12402721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.
    Alvarez V; Lee JW; Drislane FW; Westover MB; Novy J; Dworetzky BA; Rossetti AO
    Epilepsia; 2015 Aug; 56(8):1275-85. PubMed ID: 26140660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions.
    Muchohi SN; Kokwaro GO; Ogutu BR; Edwards G; Ward SA; Newton CR
    Br J Clin Pharmacol; 2008 Oct; 66(4):529-38. PubMed ID: 18662297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.
    Hu ZY; Zhao YS; Wu D; Cheng ZN
    Clin Chim Acta; 2009 Oct; 408(1-2):92-7. PubMed ID: 19654004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma.
    Hamdy DA; Brocks DR
    J Pharm Biomed Anal; 2010 Nov; 53(3):617-22. PubMed ID: 20537491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive LC-MS-MS assay for analysis of midazolam and its major metabolite in human plasma: applications to drug metabolism.
    Jabor VA; Coelho EB; Dos Santos NA; Bonato PS; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):27-32. PubMed ID: 15993663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pharmacokinetic study of midazolam for the treatment of status epilepticus in children: a preliminary report].
    Minagawa K; Watanabe T
    No To Hattatsu; 2006 Jul; 38(4):301-3. PubMed ID: 16859196
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
    Kay L; Reif PS; Belke M; Bauer S; Fründ D; Knake S; Rosenow F; Strzelczyk A
    Epilepsia; 2015 Sep; 56(9):1408-14. PubMed ID: 26216711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus.
    Ozdemir D; Gulez P; Uran N; Yendur G; Kavakli T; Aydin A
    Seizure; 2005 Mar; 14(2):129-32. PubMed ID: 15694567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.